GlassScriptPhysician profile
Nelson O Yoshioka
NPI 1487780169
$6,155.64
in general payments reported to CMS, 2019-2025
16 companies · $517 in 2025
The $517 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $637 · 2020: $195 · 2021: $915 · 2022: $717 · 2023: $873 · 2024: $2,301 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,321 · Travel and Lodging: $1,260 · Entertainment: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,321.49 |
| Travel and Lodging | $1,260.45 |
| Entertainment | $109.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,885.43 | 2019-2025 | Total30, Precision7 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $701.51 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $521.75 | 2020-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $481.75 | 2022-2025 | Infuse, Biotrue One Day |
| Coopervision INC. | $259.18 | 2019-2025 | Myday Contact Lens |
| Horizon Therapeutics Plc | $191.60 | 2023 | Tepezza |
| Optos, INC. | $187.78 | 2019-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Glaukos Corporation | $142.34 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Kala Pharmaceuticals, INC. | $125.00 | 2021 | |
| Lkc Technologies, INC. | $121.06 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $118.75 | 2025 | Xdemvy |
| Dompe US, INC. | $118.06 | 2024 | Oxervate |
| Shire North American Group INC | $117.67 | 2019 | |
| Abbvie INC. | $100.01 | 2022 | |
| Sun Pharmaceutical Industries INC. | $60.47 | 2021-2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $23.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nelson Yoshioka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.